Mission Bio, a pioneer in single-cell multi-omics solutions, has partnered with Integrated DNA Technologies (IDT), a global leader in genomics solutions, to introduce an advanced workflow for precise ...

The poster “Comprehensive On- and Off-target Validation Using ... “Single-Cell Profiling of Genome-Editing Alterations and Functional Outcomes in CRISPR-Engineered Cells,” will take place on Saturday, ...

Now, a first-in-human clinical trial is testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal cancers. The results show encouraging signs of safety ...

CRISPR Therapeutics stock is heavily shorted in the weeks going into earnings The short-sellers are betting against the name in a big way, with more than 20 million shares sold short as of the ...

Gene therapy stocks like CRISPR Therapeutics and Intellia Therapeutics are facing significant volatility in 2025, influenced by market instability and regulatory uncertainties. CRSP is better ...

CRISPR Therapeutics has exciting gene-editing candidates in the works. Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs ...

Sebastian Stan is owning his membership of The New Avengers. Earlier this morning, Marvel Studios tweeted a video of the actor, who has long portrayed James “Bucky” Buchanan Barnes in the ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

On May 5, the studio shared a video on X showing Pugh, surrounded by her co-stars, ripping off a layer of the "Thunderbolts*" poster to reveal the "New Avengers" title underneath. Need a break?

Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- <li /> Three oral and 12 poster presentations demonstrate breadth and progress o ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...